http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104569403-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-186 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
filingDate | 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104569403-B |
titleOfInvention | Innoxious positive control for hepatitis C enzyme-linked immunologic diagnosis |
abstract | The present invention relates to enzyme linked immunological kit, specifically provide a kind of innoxious positive control for hepatitis C enzyme-linked immunologic diagnosis, described positive control is mixed in 2:1 1:32 ratio by Mus HCV antigen/antibody combination and dynamics.The present invention utilizes immunological method solve the source of hepatitis C indirect method diagnostic EIA kit positive control material and avoid using human serum potential risks. |
priorityDate | 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.